Reacta Launches Milk & Egg Allergy Challenge Meals
Slice of Manufacturing Team
Jun 17, 2025
Key highlights
- First production run of milk and egg allergen meals completed
- Products support global clinical trials for new allergy treatments
- Addresses need for multi-allergen diagnostic tools
- Manufactured at MHRA-licensed UK site with cGMP compliance
- Hazelnut and cashew prototypes also in development
Source: PR Newswire
No quotes were given.
Why This Matters
The launch of pharmaceutical-grade milk and egg allergen challenge meals marks a significant advancement in food allergy diagnostics and research. With up to 46% of adults and 40% of children affected by multiple food allergies, the availability of standardized challenge meals for various allergens is critical for the development and testing of new treatments. By enhancing its product line beyond peanut-based challenges, Reacta Healthcare is meeting an urgent need in the clinical research community for multi-allergen, antigen-agnostic solutions. This progress also positions the company to support a broader array of clinical studies globally, with established regulatory submissions and scalable R&D capabilities.
